Ang Lifesciences India Ltd. (ANG)
BSE
27.90
+1.08 (+4.03%)
Closed
Aug 26, 2026
Day's Range
26.8428.16
52 wk Range
17.6349.69
Financial Statements - ANG - Ang Lifesciences India Ltd.
Revenue
928.92M▲ 0.4%
Net Income
-110.84M▲ 10.7%Net Margin -11.9%
EBITDA
12.50M▲ 223.7%
Free Cash Flow
105.90M▲ 364.3%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 928.92M | 925.40M | 1.46B | 2.19B | 3.54B | 1.53B |
| Cost of Goods | 605.40M | 600.33M | 951.12M | 1.50B | 2.27B | 1.03B |
| Gross Profit | 323.52M | 325.07M | 508.96M | 691.88M | 1.26B | 499.42M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -56.20M | -64.88M | 27.31M | 68.09M | 636.24M | 141.48M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -130.10M | -157.03M | -107.13M | 26.25M | 535M | 101.39M |
| Income Tax | -19.25M | -32.90M | -5.70M | 28.87M | 131.84M | 31.11M |
| Net Income | -110.84M | -124.13M | -101.42M | -2.62M | 403.16M | 70.27M |
| EPS Basic | - | -9.506071 | -7.807044 | -0.200792 | 38.890652 | 5.424 |
| EPS Diluted | - | -9.506071 | -7.807044 | -0.200792 | 38.890652 | 5.424 |
| Basic Shares Outstanding | - | 13.05M | 12.99M | 13.05M | 10.36M | 12.95M |
| Diluted Shares Outstanding | - | 13.05M | 12.99M | 13.05M | 10.36M | 12.95M |
| Ebit | -50.76M | -68.23M | -3.91M | 138.17M | 617.80M | 132.12M |
| Ebitda | 12.50M | 3.86M | 104.47M | 233.02M | 690.88M | 156.53M |
| Net Income Continuous Operations | -130.10M | -157.03M | -107.13M | 26.25M | 535M | 70.27M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
